ArticleJCEM case reports2026
Metachronous contralateral pheochromocytoma detected 62 years after initial surgery.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pheochromocytoma and paraganglioma (PPGL) are neuroendocrine tumors with malignant potential. Although surgery is often curative, local recurrence, metastatic disease, or new tumors can occur even decades later; therefore, long-term follow-up for at least 10 years is generally recommended. We present a case of metachronous contralateral pheochromocytoma (PCC) diagnosed 62 years after the initial surgery-the longest postoperative interval reported through our literature search. We identified an old Japanese case report of the same patient that contained valuable clinical data and treatment details, providing a unique opportunity for longitudinal comparison of the initial and later clinical courses across 6 decades. Interestingly, the second tumor showed a shift from a mixed epinephrine-norepinephrine secretory profile to a predominantly norepinephrine profile, suggesting a potential change in the tumor characteristics over time. Although the patient declined surgery and genetic testing, a genetic etiology of PCC was suspected. This case highlights the importance of lifelong follow-up for all patients with PPGL, regardless of apparent cure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.